Insulet (PODD) Acquisitions (2022 - 2023)
Insulet's (PODD) quarterly Acquisitions came in at $3.0 million in Q1 2023, down 88.46% on a YoY basis from $26.0 million in Q1 2022, and down 88.46% quarter-over-quarter from $26.0 million in Q1 2022.
Powered by 
Analysis
Insulet (PODD) Acquisitions (2022 - 2023) Analysis & Trends
Insulet (PODD) has reported Acquisitions for 2 consecutive years, with $3.0 million the latest figure, recorded in Q1 2023.
- For the quarter ending Q1 2023, Acquisitions fell 88.46% year-over-year to $3.0 million; the trailing twelve-month figure through Dec 2023 stood at $3.0 million (down 88.46% YoY), and the FY2023 full-year result was $3.0 million, down 88.46% from the prior year.
- Acquisitions slipped to $3.0 million in Q1 2023 per PODD's latest filing, from $26.0 million in the prior quarter.
- Across five years, Acquisitions topped out at $26.0 million in Q1 2022 and bottomed at $3.0 million in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | 1.16 Bn |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | 437.00 Mn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 195.00 Mn |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | - |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 16.00 Mn |
| 10 | Insulet | 9.31 Bn | 8.77 Bn | 562.60 Mn | - |